Revolution Medicines Stock Investor Sentiment

RVMD Stock  USD 59.33  1.27  2.10%   
About 63% of Revolution Medicines' investor base is looking to short. The analysis of the overall investor sentiment regarding Revolution Medicines suggests that many traders are alarmed. The current market sentiment, together with Revolution Medicines' historical and current headlines, can help investors time the market. In addition, many technical investors use Revolution Medicines stock news signals to limit their universe of possible portfolio assets.
  

Revolution Medicines Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Revolution Medicines can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
few days ago at thelincolnianonline.com         
Revolution Medicines Price Target Raised to 70.00
news
few days ago at gurufocus.com         
Decoding Revolution Medicines Inc A Strategic SWOT Insight
Gurufocus Stories at Macroaxis
few days ago at thelincolnianonline.com         
Revolution Medicines Price Target Raised to 68.00 at Needham Company LLC
news
few days ago at gurufocus.com         
Wellington Management Group LLP Reduces Stake in Revolution Medicines Inc
Gurufocus Stories at Macroaxis
few days ago at insidermonkey.com         
Revolution Medicines, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
few days ago at investing.com         
Revolution Medicines general counsel sells 360,000 in stock
Investing News at Macroaxis
few days ago at gurufocus.com         
Revolution Medicines Inc Q3 2024 Earnings Call Highlights Strategic Advances Amid ...
Gurufocus Stories at Macroaxis
few days ago at thelincolnianonline.com         
What is HC Wainwrights Estimate for RVMD Q3 Earnings?
news
few days ago at finance.yahoo.com         
Revolution Medicines Inc Q3 2024 Earnings Call Highlights Strategic Advances Amid ...
Yahoo News
six days ago at finance.yahoo.com         
Revolution Medicines Reports Third Quarter 2024 Financial Results and Update on Corporate Progress
Yahoo News
six days ago at finance.yahoo.com         
Disposition of 6000 shares by Cislini Jeff of Revolution Medicines at 36.57 subject to Rule 16b-3
Yahoo News
over a week ago at gurufocus.com         
Revolution Medicines Inc Q3 2024 Earnings Report Preview What To Look For
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Revolution Medicines Inc Q3 2024 Earnings Report Preview What To Look For
Yahoo News
over a week ago at investing.com         
Revolution Medicines CEO Mark A. Goldsmith sells 3.88 million in stock
Investing News at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of 36600 shares by Mark Goldsmith of Revolution Medicines at 0.49 subject to Rule 16b-3
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Revolution Medicines that are available to investors today. That information is available publicly through Revolution media outlets and privately through word of mouth or via Revolution internal channels. However, regardless of the origin, that massive amount of Revolution data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Revolution Medicines news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Revolution Medicines relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Revolution Medicines' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Revolution Medicines alpha.

Revolution Medicines Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 16667 shares by Kelsey Stephen Michael of Revolution Medicines at 4.09 subject to Rule 16b-3
09/13/2024
2
Disposition of 1454 shares by Cislini Jeff of Revolution Medicines at 44.1853 subject to Rule 16b-3
09/16/2024
3
Casdin Capital, LLC Increases Stake in Codexis Inc
09/26/2024
4
Disposition of 6000 shares by Cislini Jeff of Revolution Medicines at 36.57 subject to Rule 16b-3
10/11/2024
5
Disposition of 16666 shares by Kelsey Stephen Michael of Revolution Medicines at 4.09 subject to Rule 16b-3
10/14/2024
6
Revolution Medicines CEO sells 1.51 million in stock
10/15/2024
7
Insider Selling Revolution Medicines, Inc. Insider Sells 16,666 Shares of Stock
10/16/2024
8
Revolution Medicines Trading Up 3.2 percent Heres What Happened
10/23/2024
9
Revolution Medicines Presents Initial Data from RMC-9805 Monotherapy Study in Patients with Advanced Pancreatic Ductal Adenocarcinoma
10/25/2024
10
Disposition of 5000 shares by Patel Sushil of Revolution Medicines at 24.84 subject to Rule 16b-3
10/31/2024
11
Disposition of 5000 shares by Mark Goldsmith of Revolution Medicines at 55.0268 subject to Rule 16b-3
11/01/2024
12
Disposition of 36600 shares by Mark Goldsmith of Revolution Medicines at 0.49 subject to Rule 16b-3
11/04/2024
13
Revolution Medicines Inc Q3 2024 Earnings Report Preview What To Look For
11/05/2024
14
Revolution Medicines Reports Third Quarter 2024 Financial Results and Update on Corporate Progress
11/06/2024
15
Revolution Medicines Inc Q3 2024 Earnings Call Highlights Strategic Advances Amid ...
11/07/2024
16
Wellington Management Group LLP Reduces Stake in Revolution Medicines Inc
11/08/2024

Complementary Tools for Revolution Stock analysis

When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Transaction History
View history of all your transactions and understand their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets